Advertisement

Topics

Sweden Grants Marketing Authorization to Allergan's Belkyra

12:00 EDT 19 Oct 2016 | Drug Discovery Development

Belkyra is the only non-surgical injectable treatment for reduction of fullness under the chin that has undergone rigorous clinical evaluation.
Topics: 

Original Article: Sweden Grants Marketing Authorization to Allergan's Belkyra

NEXT ARTICLE

More From BioPortfolio on "Sweden Grants Marketing Authorization to Allergan's Belkyra"

Quick Search
Advertisement